Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Weighted Average)
Others
Ratios

NewGenIvf (NIVF) Net Income towards Common Stockholders (2024 - 2025)

Historic Net Income towards Common Stockholders for NewGenIvf (NIVF) over the last 2 years, with Q3 2025 value amounting to $16.8 million.

  • NewGenIvf's Net Income towards Common Stockholders rose 8482254.12% to $16.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.3 million, marking a year-over-year change of. This contributed to the annual value of -$474101.0 for FY2024, which is 53728.99% down from last year.
  • According to the latest figures from Q3 2025, NewGenIvf's Net Income towards Common Stockholders is $16.8 million, which was up 8482254.12% from -$542684.0 recorded in Q4 2024.
  • Over the past 5 years, NewGenIvf's Net Income towards Common Stockholders peaked at $16.8 million during Q3 2025, and registered a low of -$542684.0 during Q4 2024.